The sector is characterized by the presence in the Region of some of the major Italian pharmaceutical industries (also in the veterinary field), with a strong propensity to invest in innovative research, skills on the most modern genome study methods and interpretation of its variations , and can count on a chain of research activities ranging from drug discovery to new drug delivery formulations and packaging, as well as interests in health products and the spa industry, supported by a significant offer of services that meet the regulatory requirements for transfer to the market.
The Strategic Objectives of the VC Pharmaceutical and Omic Sciences (POSERR) are:
- Strategic Objective 1 – Development of molecules and biomolecules, innovative therapies, in vitro diagnostic devices and silicon physiological models for personalized medicine, for the treatment and prevention of chronic or rare diseases and degenerative diseases linked and not to aging.
- Strategic Objective 2 – New pharmaceutical, biotechnological, drug delivery and omics approaches, aimed at preventing and combating drug-resistance and drug-tolerance in particular in cancer diseases, infectious diseases and chronic therapies.
- Strategic Objective 3 – Development of new systems for the industrial production of medicines, drug delivery platforms and medical devices.
The Value Chain are chaired by a Chair and a Vice Chair, which for the VC POSERR are:
Chair of the Value Chain: Ruggero Bettini
Affiliation: Università degli Studi di Parma
Vice Chair of the Value Chain: Luca Nicola Ferraro
Affiliation: Università degli Studi di Ferrara